Research library / NAD+ (NR, NMN)

CRCT (crossover) · 24 adults 55-79

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults

C Martens, B Denman, M Mazzo, M Armstrong, N Reisdorph, M McQueen et al.. Nature Communications. 2018.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
1,000 mg per day of NR for 6 weeks was well tolerated and raised blood NAD+.
Limits
Small, short; functional effects exploratory.
Source
doi.org/10.1038/s41467-018-03421-7 · PubMed 29599478 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack.